Is IQQQ High Income ETF Good to Buy?
The Proshares NASDAQ-100 High Income ETF (IQQQ) is a covered…
Sell
8
CVRX Quote, Financials, Valuation and Earnings
Last price:
$6.26
Seasonality move
:
23.43%
Day range:
$6.02 - $6.28
52-week range:
$5.87 - $18.55
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.75x
P/B ratio:
2.29x
Volume:
241.6K
Avg. volume:
405.2K
1-year change:
-60.22%
Market cap:
$162.7M
Revenue:
$51.3M
EPS (TTM):
-$2.69
Analysts' Opinion
-
Consensus RatingCVRx has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $16.83, CVRx has an estimated upside of 169.33% from its current price of $6.25.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $14.00 representing -- downside risk from its current price of $6.25.
Fair Value
-
According to the consensus of 6 analysts, CVRx has 169.33% upside to fair value with a price target of $16.83 per share.
CVRX vs. S&P 500
-
Over the past 5 trading days, CVRx has overperformed the S&P 500 by 1.53% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
CVRx does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CVRx has grown year-over-year revenues for 0 quarters straight. In the most recent quarter CVRx reported revenues of $15.3M.
Earnings Growth
-
CVRx has grown year-over-year earnings for 0 quarters straight. In the most recent quarter CVRx reported earnings per share of -$0.43.
Enterprise value:
106.1M
EV / Invested capital:
--
Price / LTM sales:
2.75x
EV / EBIT:
--
EV / Revenue:
2.07x
PEG ratio (5yr expected):
-0.06x
EV / Free cash flow:
-2.62x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$43M
Return On Assets:
-51.83%
Net Income Margin (TTM):
-116.91%
Return On Equity:
-89.85%
Return On Invested Capital:
-57.66%
Operating Margin:
-66.97%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $22.5M | $39.3M | $51.3M | $11.3M | $15.3M | |
| Gross Profit | $17.5M | $33M | $43M | $9.6M | $12.8M | |
| Operating Income | -$42.5M | -$43.1M | -$59.5M | -$9.7M | -$10.3M | |
| EBITDA | -$40.7M | -$38.7M | -$54.9M | -$8.4M | -$9M | |
| Diluted EPS | -$2.02 | -$1.98 | -$2.69 | -$0.44 | -$0.43 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $64.3M | $151.1M | $122.9M | $112.1M | $129.8M | |
| Total Assets | $64.8M | $152.5M | $124.9M | $115.2M | $133.4M | |
| Current Liabilities | $8M | $5.9M | $8.1M | $7.9M | $10.8M | |
| Total Liabilities | $358M | $6.6M | $15.8M | $39.3M | $62.4M | |
| Total Equity | -$293.2M | $146M | $109.2M | $75.9M | $71.1M | |
| Total Debt | $19.3M | -- | $6.7M | $29.2M | $49.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$42.7M | -$39M | -$39.1M | -$7.8M | -$8M | |
| Cash From Investing | -$685K | -$591K | -$1.4M | -$169K | -$52K | |
| Cash From Financing | $7.5M | $24M | $55.9M | $15.6M | $13.8M | |
| Free Cash Flow | -$43.4M | -$39.6M | -$40.5M | -$8M | -$8.1M | |
CVRX
Sector
Market Cap
$162.7M
$35M
Price % of 52-Week High
--
42.2%
Dividend Yield
0%
0%
Shareholder Yield
-12.32%
-0.81%
1-Year Price Total Return
-60.22%
-41.61%
Beta (5-Year)
--
0.742
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$6.43
200-day SMA
Sell
Level
$11.60
Bollinger Bands (100)
Sell
Level
10.64 - 15.96
Chaikin Money Flow
Sell
Level
-4.4M
20-day SMA
Sell
Level
$10.00
Relative Strength Index (RSI14)
Sell
Level
25.78
ADX Line
Sell
Level
41.52
Williams %R
Buy
Level
-94.7152
50-day SMA
Sell
Level
$11.83
MACD (12, 26)
Sell
Level
-1.78
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
3.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-2.4693)
Sell
CA Score
(Annual)
Level (-1.8977)
Buy
Beneish M-Score
(Annual)
Level (-3.1936)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (2.7392)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Stock Forecast FAQ
In the current month, CVRX has received 5 Buy ratings 1 Hold ratings, and 0 Sell ratings. The CVRX average analyst price target in the past 3 months is $16.83.
-
Where Will CVRx Stock Be In 1 Year?
According to analysts, the consensus estimate is that CVRx share price will rise to $16.83 per share over the next 12 months.
-
What Do Analysts Say About CVRx?
Analysts are divided on their view about CVRx share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CVRx is a Sell and believe this share price will drop from its current level to $14.00.
-
What Is CVRx's Price Target?
The price target for CVRx over the next 1-year time period is forecast to be $16.83 according to 6 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is CVRX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CVRx is a Buy. 5 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of CVRX?
You can purchase shares of CVRx via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CVRx shares.
-
What Is The CVRx Share Price Today?
CVRx was last trading at $6.26 per share. This represents the most recent stock quote for CVRx. Yesterday, CVRx closed at $6.25 per share.
-
How To Buy CVRx Stock Online?
In order to purchase CVRx stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Can Spotify Ever Become Consistently Profitable?
Spotify (NYSE:SPOT) owns more than 30% market share as the most…
Is American Express a Buy, Sell or Hold?
American Express (NYSE:AXP) holds a notable place in Warren Buffett’s…
Stock Ideas
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 32x
Sell
47
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 31x
Sell
46
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 35x
Alerts
Sell
23
UNH alert for Apr 20
UnitedHealth Group [UNH] is down 22.4% over the past day.
Sell
32
MAN alert for Apr 20
ManpowerGroup [MAN] is down 19.07% over the past day.
Sell
24
GPN alert for Apr 20
Global Payments [GPN] is down 17.44% over the past day.
